FL_genes.md
... ...
@@ -1,7 +1,6 @@
1 1
# FL genes
2 2
3 3
## Origins of FL genes
4
-
5 4
```mermaid
6 5
---
7 6
config:
... ...
@@ -41,131 +40,131 @@ RNA-seq/WGS, Morin 2011, 15
41 40
42 41
### *66 total*
43 42
44
-| Gene | Tier | Relevant references |
45
-|:----------------------:|:-------:|:---------------------------------------------------------------------------------|
46
-| [ACTB](ACTB) | 1, aSHM | Lohr et al. 2012 |
47
-| [ARID1A](ARID1A) | 1 | Krysiak et al. 2017; Zhang et al. 2013; Love et al. 2012 |
48
-| [ATP6AP1](ATP6AP1) | 1 | Okosun et al. 2016 |
49
-| [ATP6V1B2](ATP6V1B2) | 1 | Okosun et al. 2016 |
50
-| [B2M](B2M) | 1 | Pararajalingam et al. 2020; Morin et al. 2011 |
51
-| [BCL2](BCL2) | 1, aSHM | Tanaka et al. 1992; Burkhardt et al. 2022; Morin et al. 2011 |
52
-| [BCL6](BCL6) | 1, aSHM | Morin et al. 2011; Love et al. 2012 |
53
-| [BCL7A](BCL7A) | 1, aSHM | Arthur et al. 2018; Krysiak et al. 2017; Grande et al. 2019 |
54
-| [BIRC6](BIRC6) | 1 | Reddy et al. 2017 |
55
-| [BTG1](BTG1) | 1, aSHM | Morin et al. 2011; Burkhardt et al. 2022 |
56
-| [BTG2](BTG2) | 1, aSHM | Love et al. 2012; Morin et al. 2011 |
57
-| [BTK](BTK) | 1 | Albuquerque et al. 2017; Krysiak et al. 2017 |
58
-| [CARD11](CARD11) | 1 | Lenz et al. 2008; Wu et al. 2016; Panea et al. 2019; Morin et al. 2011 |
59
-| [CCND3](CCND3) | 1 | Morin et al. 2011; Richter et al. 2012 |
60
-| [CD83](CD83) | 1, aSHM | Russler-Germain et al. 2023; Morin et al. 2013; Panea et al. 2019 |
61
-| [CREBBP](CREBBP) | 1 | Laura Pasqualucci, Dominguez-Sola, et al. 2011; Love et al. 2012 |
62
-| [CTSS](CTSS) | 1 | Bararia et al. 2020 |
63
-| [DTX1](DTX1) | 1, aSHM | Schmitz et al. 2018; Panea et al. 2019 |
64
-| [EBF1](EBF1) | 1, aSHM | Bohle et al. 2013; Thomas et al. 2023 |
65
-| [EEF1A1](EEF1A1) | 1 | Hübschmann et al. 2021 |
66
-| [EP300](EP300) | 1 | Laura Pasqualucci, Dominguez-Sola, et al. 2011; Panea et al. 2019 |
67
-| [EZH2](EZH2) | 1 | Love et al. 2012; Morin et al. 2010 |
68
-| [FAS](FAS) | 1 | Scholl et al. 2007 |
69
-| [FOXO1](FOXO1) | 1 | Morin et al. 2011; Schmitz et al. 2012 |
70
-| [GNA13](GNA13) | 1 | Love et al. 2012; Morin et al. 2011 |
71
-| [GNAI2](GNAI2) | 1 | Grande et al. 2019; Morin et al. 2013 |
72
-| [HIST1H1B](HIST1H1B) | 1, aSHM | Chapuy et al. 2018; Krysiak et al. 2017 |
73
-| [HIST1H1C](HIST1H1C) | 1, aSHM | Panea et al. 2019; Morin et al. 2011 |
74
-| [HIST1H1D](HIST1H1D) | 1, aSHM | Krysiak et al. 2017; Morin et al. 2013 |
75
-| [HIST1H1E](HIST1H1E) | 1, aSHM | Grande et al. 2019; Morin et al. 2013; Krysiak et al. 2017 |
76
-| [HIST1H2AC](HIST1H2AC) | 1, aSHM | Morin et al. 2013; Krysiak et al. 2017 |
77
-| [HIST1H2AG](HIST1H2AG) | 1, aSHM | Krysiak et al. 2017; Morin et al. 2013; Panea et al. 2019 |
78
-| [HIST1H2AM](HIST1H2AM) | 1, aSHM | Panea et al. 2019; Krysiak et al. 2017 |
79
-| [HIST1H2BC](HIST1H2BC) | 1, aSHM | Krysiak et al. 2017; Reddy et al. 2017 |
80
-| [HIST1H2BD](HIST1H2BD) | 1, aSHM | Krysiak et al. 2017 |
81
-| [HIST1H2BG](HIST1H2BG) | 1, aSHM | Krysiak et al. 2017 |
82
-| [HIST1H3B](HIST1H3B) | 1, aSHM | Zhang et al. 2013 |
83
-| [HIST1H3G](HIST1H3G) | 1, aSHM | Krysiak et al. 2017 |
84
-| [HVCN1](HVCN1) | 1 | Krysiak et al. 2017 |
85
-| [IRF4](IRF4) | 1, aSHM | Morin et al. 2011 |
86
-| [IRF8](IRF8) | 1, aSHM | Panea et al. 2019; Morin et al. 2011 |
87
-| [ITPKB](ITPKB) | 1, aSHM | Schmitz et al. 2018 |
88
-| [KLF2](KLF2) | 1, aSHM | Laura Pasqualucci, Trifonov, et al. 2011 |
89
-| [KLHL6](KLHL6) | 1, aSHM | Morin et al. 2011; Panea et al. 2019 |
90
-| [KMT2D](KMT2D) | 1 | Beà et al. 2013; Morin et al. 2011; Grande et al. 2019 |
91
-| [LTB](LTB) | 1, aSHM | Chapuy et al. 2018; Panea et al. 2019 |
92
-| [MAP2K1](MAP2K1) | 1 | Shin et al. 2015; Louissaint et al. 2016 |
93
-| [MEF2B](MEF2B) | 1, aSHM | Morin et al. 2011; Beà et al. 2013 |
94
-| [MEF2C](MEF2C) | 1, aSHM | Arthur et al. 2018 |
95
-| [PCLO](PCLO) | 1 | Lohr et al. 2012 |
96
-| [PIM1](PIM1) | 1, aSHM | L. Pasqualucci et al. 2001; Burkhardt et al. 2022 |
97
-| [POU2AF1](POU2AF1) | 1 | Krysiak et al. 2017 |
98
-| [POU2F2](POU2F2) | 1 | Krysiak et al. 2017; Zhang et al. 2013 |
99
-| [PTPRD](PTPRD) | 1 | |
100
-| [RRAGC](RRAGC) | 1 | Okosun et al. 2016 |
101
-| [S1PR2](S1PR2) | 1, aSHM | Morin et al. 2011; Muppidi et al. 2014 |
102
-| [SGK1](SGK1) | 1, aSHM | Morin et al. 2011 |
103
-| [SMARCA4](SMARCA4) | 1 | Richter et al. 2012; Nadeu et al. 2020; Krysiak et al. 2017; Zhang et al. 2013 |
104
-| [SOCS1](SOCS1) | 1, aSHM | Morin et al. 2011 |
105
-| [STAT6](STAT6) | 1 | Yildiz et al. 2015 |
106
-| [TBL1XR1](TBL1XR1) | 1 | Mareschal et al. 2016 |
107
-| [TMSB4X](TMSB4X) | 1, aSHM | Albuquerque et al. 2017 |
108
-| [TNFAIP3](TNFAIP3) | 1 | Compagno et al. 2009 |
109
-| [TNFRSF14](TNFRSF14) | 1 | Cheung et al. 2010 |
110
-| [TP53](TP53) | 1 | Wilda et al. 2004; Morin et al. 2011; Beà et al. 2013 |
111
-| [VMA21](VMA21) | 1 | Hübschmann et al. 2021 |
43
+| Gene | Tier | Relevant references |
44
+|:----------------------:|:-------:|:--------------------------------------------------------------------------------------------------------|
45
+| [ACTB](ACTB) | 1, aSHM | Lohr et al. 2012; Wienand et al. 2019 |
46
+| [ARID1A](ARID1A) | 1 | Zhang et al. 2013; Wienand et al. 2019; Love et al. 2012; Krysiak et al. 2017; Rossi et al. 2012 |
47
+| [ATP6AP1](ATP6AP1) | 1 | Okosun et al. 2016 |
48
+| [ATP6V1B2](ATP6V1B2) | 1 | Okosun et al. 2016 |
49
+| [B2M](B2M) | 1 | Morin et al. 2011; Pararajalingam et al. 2020; Reichel et al. 2015 |
50
+| [BCL2](BCL2) | 1, aSHM | Sarkozy et al. 2021; Tanaka et al. 1992; Burkhardt et al. 2022; Morin et al. 2011 |
51
+| [BCL6](BCL6) | 1, aSHM | Morin et al. 2011; Love et al. 2012 |
52
+| [BCL7A](BCL7A) | 1, aSHM | Reichel et al. 2015; Grande et al. 2019; Krysiak et al. 2017; Arthur et al. 2018 |
53
+| [BIRC6](BIRC6) | 1 | Sarkozy et al. 2021; Reddy et al. 2017 |
54
+| [BTG1](BTG1) | 1, aSHM | Sarkozy et al. 2021; Burkhardt et al. 2022; Morin et al. 2011 |
55
+| [BTG2](BTG2) | 1, aSHM | Love et al. 2012; Morin et al. 2011 |
56
+| [BTK](BTK) | 1 | Krysiak et al. 2017; Albuquerque et al. 2017 |
57
+| [CARD11](CARD11) | 1 | Yan et al. 2012; Lenz et al. 2008; Morin et al. 2011; Panea et al. 2019; Wu et al. 2016 |
58
+| [CCND3](CCND3) | 1 | Desch et al. 2020; Jallades et al. 2017; Richter et al. 2012; Morin et al. 2011 |
59
+| [CD83](CD83) | 1, aSHM | Russler-Germain et al. 2023; Panea et al. 2019; Duns et al. 2021; Morin et al. 2013 |
60
+| [CREBBP](CREBBP) | 1 | Duns et al. 2021; Laura Pasqualucci, Dominguez-Sola, et al. 2011; Love et al. 2012; Parry et al. 2013 |
61
+| [CTSS](CTSS) | 1 | Bararia et al. 2020 |
62
+| [DTX1](DTX1) | 1, aSHM | Rossi et al. 2012; Panea et al. 2019; Gomez et al. 2023; Schmitz et al. 2018 |
63
+| [EBF1](EBF1) | 1, aSHM | Reichel et al. 2015; Thomas et al. 2023; Bohle et al. 2013 |
64
+| [EEF1A1](EEF1A1) | 1 | Reichel et al. 2015; Hübschmann et al. 2021 |
65
+| [EP300](EP300) | 1 | Laura Pasqualucci, Dominguez-Sola, et al. 2011; Panea et al. 2019; Rossi et al. 2012 |
66
+| [EZH2](EZH2) | 1 | Morin et al. 2010; Love et al. 2012; Mottok et al. 2019 |
67
+| [FAS](FAS) | 1 | Scholl et al. 2007; Spina et al. 2016 |
68
+| [FOXO1](FOXO1) | 1 | Morin et al. 2011; Schmitz et al. 2012; Duns et al. 2021 |
69
+| [GNA13](GNA13) | 1 | Love et al. 2012; Morin et al. 2011; Reichel et al. 2015 |
70
+| [GNAI2](GNAI2) | 1 | Morin et al. 2013; Grande et al. 2019 |
71
+| [HIST1H1B](HIST1H1B) | 1, aSHM | Sarkozy et al. 2021; Chapuy et al. 2018; Krysiak et al. 2017 |
72
+| [HIST1H1C](HIST1H1C) | 1, aSHM | Morin et al. 2011; Panea et al. 2019 |
73
+| [HIST1H1D](HIST1H1D) | 1, aSHM | Krysiak et al. 2017; Morin et al. 2013; Jallades et al. 2017 |
74
+| [HIST1H1E](HIST1H1E) | 1, aSHM | Reichel et al. 2015; Morin et al. 2013; Krysiak et al. 2017; Grande et al. 2019 |
75
+| [HIST1H2AC](HIST1H2AC) | 1, aSHM | Krysiak et al. 2017; Morin et al. 2013 |
76
+| [HIST1H2AG](HIST1H2AG) | 1, aSHM | Krysiak et al. 2017; Panea et al. 2019; Morin et al. 2013; Rossi et al. 2012 |
77
+| [HIST1H2AM](HIST1H2AM) | 1, aSHM | Panea et al. 2019; Krysiak et al. 2017 |
78
+| [HIST1H2BC](HIST1H2BC) | 1, aSHM | Mottok et al. 2019; Krysiak et al. 2017; Reddy et al. 2017 |
79
+| [HIST1H2BD](HIST1H2BD) | 1, aSHM | Krysiak et al. 2017 |
80
+| [HIST1H2BG](HIST1H2BG) | 1, aSHM | Krysiak et al. 2017 |
81
+| [HIST1H3B](HIST1H3B) | 1, aSHM | Zhang et al. 2013; Reichel et al. 2015 |
82
+| [HIST1H3G](HIST1H3G) | 1, aSHM | Krysiak et al. 2017 |
83
+| [HVCN1](HVCN1) | 1 | Krysiak et al. 2017 |
84
+| [IRF4](IRF4) | 1, aSHM | Mottok et al. 2019; Morin et al. 2011 |
85
+| [IRF8](IRF8) | 1, aSHM | Panea et al. 2019; Morin et al. 2011; Mottok et al. 2019 |
86
+| [ITPKB](ITPKB) | 1, aSHM | Schmitz et al. 2018; Reichel et al. 2015 |
87
+| [KLF2](KLF2) | 1, aSHM | Laura Pasqualucci, Trifonov, et al. 2011; Desch et al. 2020; Jallades et al. 2017 |
88
+| [KLHL6](KLHL6) | 1, aSHM | Panea et al. 2019; Ganapathi et al. 2016; Morin et al. 2011 |
89
+| [KMT2D](KMT2D) | 1 | Rossi et al. 2012; Desch et al. 2020; Morin et al. 2011; Beà et al. 2013; Grande et al. 2019 |
90
+| [LTB](LTB) | 1, aSHM | Desch et al. 2020; Chapuy et al. 2018; Panea et al. 2019 |
91
+| [MAP2K1](MAP2K1) | 1 | Shin et al. 2015; Louissaint et al. 2016 |
92
+| [MEF2B](MEF2B) | 1, aSHM | Beà et al. 2013; Morin et al. 2011 |
93
+| [MEF2C](MEF2C) | 1, aSHM | Arthur et al. 2018 |
94
+| [PCLO](PCLO) | 1 | Lohr et al. 2012 |
95
+| [PIM1](PIM1) | 1, aSHM | Duns et al. 2021; L. Pasqualucci et al. 2001; Burkhardt et al. 2022 |
96
+| [POU2AF1](POU2AF1) | 1 | Krysiak et al. 2017 |
97
+| [POU2F2](POU2F2) | 1 | Zhang et al. 2013; Krysiak et al. 2017 |
98
+| [PTPRD](PTPRD) | 1 | Spina et al. 2016 |
99
+| [RRAGC](RRAGC) | 1 | Okosun et al. 2016 |
100
+| [S1PR2](S1PR2) | 1, aSHM | Morin et al. 2011; Muppidi et al. 2014 |
101
+| [SGK1](SGK1) | 1, aSHM | Morin et al. 2011; Duns et al. 2021 |
102
+| [SMARCA4](SMARCA4) | 1 | Zhang et al. 2013; Nadeu et al. 2020; Krysiak et al. 2017; Richter et al. 2012 |
103
+| [SOCS1](SOCS1) | 1, aSHM | Morin et al. 2011; Weniger et al. 2006 |
104
+| [STAT6](STAT6) | 1 | Yildiz et al. 2015; Ritz et al. 2009 |
105
+| [TBL1XR1](TBL1XR1) | 1 | Rossi et al. 2012; Mareschal et al. 2016 |
106
+| [TMSB4X](TMSB4X) | 1, aSHM | Albuquerque et al. 2017 |
107
+| [TNFAIP3](TNFAIP3) | 1 | Schmitz et al. 2009; Compagno et al. 2009; Rossi et al. 2011 |
108
+| [TNFRSF14](TNFRSF14) | 1 | Cheung et al. 2010; Spina et al. 2016 |
109
+| [TP53](TP53) | 1 | Wilda et al. 2004; Rossi et al. 2012; Beà et al. 2013; Tiacci et al. 2018; Morin et al. 2011 |
110
+| [VMA21](VMA21) | 1 | Hübschmann et al. 2021 |
112 111
113 112
## Tier 2 FL genes
114 113
115 114
### *50 total*
116 115
117
-| Gene | Tier | Relevant references |
118
-|:----------------------:|:-------:|:-------------------------------------------------------------------|
119
-| [ABL2](ABL2) | 2 | Russler-Germain et al. 2023 |
120
-| [ACTG1](ACTG1) | 2, aSHM | Hübschmann et al. 2021 |
121
-| [ATP6V1A](ATP6V1A) | 2 | Hübschmann et al. 2021 |
122
-| [BCL10](BCL10) | 2 | Morin et al. 2011; Russler-Germain et al. 2023 |
123
-| [CCDC42BPB](CCDC42BPB) | 2 | Hübschmann et al. 2021 |
124
-| [CD70](CD70) | 2 | Russler-Germain et al. 2023; Morin et al. 2011 |
125
-| [CD79B](CD79B) | 2 | Panea et al. 2019; Morin et al. 2011 |
126
-| [CILP](CILP) | 2 | Russler-Germain et al. 2023 |
127
-| [CPNE8](CPNE8) | 2 | Hübschmann et al. 2021 |
128
-| [CXCR4](CXCR4) | 2, aSHM | Panea et al. 2019; Khodabakhshi et al. 2012; Krysiak et al. 2017 |
129
-| [CYP2A6](CYP2A6) | 2 | Russler-Germain et al. 2023 |
130
-| [DDX3X](DDX3X) | 2 | Schmitz et al. 2012, 2018 |
131
-| [DHX15](DHX15) | 2 | Hübschmann et al. 2021 |
132
-| [DUSP2](DUSP2) | 2, aSHM | Morin et al. 2013 |
133
-| [EGR1](EGR1) | 2 | Krysiak et al. 2017 |
134
-| [FZR1](FZR1) | 2 | Hübschmann et al. 2021 |
135
-| [GBP7](GBP7) | 2 | Russler-Germain et al. 2023 |
136
-| [GRM6](GRM6) | 2 | Russler-Germain et al. 2023 |
137
-| [HIST1H2BM](HIST1H2BM) | 2, aSHM | Krysiak et al. 2017 |
138
-| [HIST1H3I](HIST1H3I) | 2, aSHM | Panea et al. 2019; Krysiak et al. 2017 |
139
-| [HLA-B](HLA-B) | 2 | |
140
-| [HNRNPD](HNRNPD) | 2 | |
141
-| [IGLL5](IGLL5) | 2, aSHM | Russler-Germain et al. 2023; Panea et al. 2019 |
142
-| [JUP](JUP) | 2 | Hübschmann et al. 2021 |
143
-| [KIR3DL1](KIR3DL1) | 2 | Russler-Germain et al. 2023 |
144
-| [LAPTM5](LAPTM5) | 2 | Hübschmann et al. 2021 |
145
-| [MAGEC1](MAGEC1) | 2 | Russler-Germain et al. 2023 |
146
-| [MAP7D1](MAP7D1) | 2 | Russler-Germain et al. 2023 |
147
-| [MGEA5](MGEA5) | 2 | Hübschmann et al. 2021 |
148
-| [MKI67](MKI67) | 2 | Russler-Germain et al. 2023; Schmitz et al. 2012 |
149
-| [MYC](MYC) | 2, aSHM | L. Pasqualucci et al. 2001; Johnston and Carroll 1992 |
150
-| [MYCBP2](MYCBP2) | 2 | Hübschmann et al. 2021 |
151
-| [MYD88](MYD88) | 2 | Ngo et al. 2011 |
152
-| [NFKBIA](NFKBIA) | 2 | Russler-Germain et al. 2023; Lake et al. 2009 |
153
-| [OR8H2](OR8H2) | 2 | Russler-Germain et al. 2023 |
154
-| [P2RY8](P2RY8) | 2 | Lohr et al. 2012; Muppidi et al. 2014 |
155
-| [PDS5B](PDS5B) | 2 | Hübschmann et al. 2021; Morin et al. 2013 |
156
-| [PPP4C](PPP4C) | 2 | Hübschmann et al. 2021 |
157
-| [PRKDC](PRKDC) | 2 | Hübschmann et al. 2021; Schmitz et al. 2018 |
158
-| [PZP](PZP) | 2 | Russler-Germain et al. 2023 |
159
-| [RBM6](RBM6) | 2 | Hübschmann et al. 2021 |
160
-| [SESN1](SESN1) | 2 | Oricchio et al. 2017 |
161
-| [SHROOM3](SHROOM3) | 2 | Russler-Germain et al. 2023 |
162
-| [SRRM2](SRRM2) | 2 | Russler-Germain et al. 2023; Morin et al. 2013 |
163
-| [STAB2](STAB2) | 2 | Russler-Germain et al. 2023 |
164
-| [TMEM30A](TMEM30A) | 2 | Morin et al. 2011 |
165
-| [TPP1](TPP1) | 2 | Hübschmann et al. 2021 |
166
-| [XIRP2](XIRP2) | 2 | Russler-Germain et al. 2023 |
167
-| [ZC3H12A](ZC3H12A) | 2 | Arthur et al. 2018 |
168
-| [ZNF608](ZNF608) | 2 | Zhang et al. 2013; Krysiak et al. 2017 |
116
+| Gene | Tier | Relevant references |
117
+|:----------------------:|:-------:|:------------------------------------------------------------------------------------------------|
118
+| [ABL2](ABL2) | 2 | Russler-Germain et al. 2023 |
119
+| [ACTG1](ACTG1) | 2, aSHM | Hübschmann et al. 2021; Spina et al. 2016; Desch et al. 2020 |
120
+| [ATP6V1A](ATP6V1A) | 2 | Hübschmann et al. 2021 |
121
+| [BCL10](BCL10) | 2 | Spina et al. 2016; Russler-Germain et al. 2023; Morin et al. 2011 |
122
+| [CCDC42BPB](CCDC42BPB) | 2 | Hübschmann et al. 2021 |
123
+| [CD70](CD70) | 2 | Morin et al. 2011; Russler-Germain et al. 2023 |
124
+| [CD79B](CD79B) | 2 | Morin et al. 2011; Panea et al. 2019 |
125
+| [CILP](CILP) | 2 | Russler-Germain et al. 2023 |
126
+| [CPNE8](CPNE8) | 2 | Hübschmann et al. 2021 |
127
+| [CXCR4](CXCR4) | 2, aSHM | Krysiak et al. 2017; Panea et al. 2019; Khodabakhshi et al. 2012 |
128
+| [CYP2A6](CYP2A6) | 2 | Russler-Germain et al. 2023 |
129
+| [DDX3X](DDX3X) | 2 | Schmitz et al. 2018, 2012; Mottok et al. 2019 |
130
+| [DHX15](DHX15) | 2 | Hübschmann et al. 2021 |
131
+| [DUSP2](DUSP2) | 2, aSHM | Morin et al. 2013; Duns et al. 2021 |
132
+| [EGR1](EGR1) | 2 | Krysiak et al. 2017; Rossi et al. 2012; Reichel et al. 2015 |
133
+| [FZR1](FZR1) | 2 | Hübschmann et al. 2021 |
134
+| [GBP7](GBP7) | 2 | Russler-Germain et al. 2023 |
135
+| [GRM6](GRM6) | 2 | Russler-Germain et al. 2023 |
136
+| [HIST1H2BM](HIST1H2BM) | 2, aSHM | Krysiak et al. 2017 |
137
+| [HIST1H3I](HIST1H3I) | 2, aSHM | Panea et al. 2019; Krysiak et al. 2017 |
138
+| [HLA-B](HLA-B) | 2 | Wienand et al. 2019 |
139
+| [HNRNPD](HNRNPD) | 2 | |
140
+| [IGLL5](IGLL5) | 2, aSHM | Russler-Germain et al. 2023; Desch et al. 2020; Panea et al. 2019 |
141
+| [JUP](JUP) | 2 | Hübschmann et al. 2021 |
142
+| [KIR3DL1](KIR3DL1) | 2 | Russler-Germain et al. 2023 |
143
+| [LAPTM5](LAPTM5) | 2 | Hübschmann et al. 2021 |
144
+| [MAGEC1](MAGEC1) | 2 | Russler-Germain et al. 2023 |
145
+| [MAP7D1](MAP7D1) | 2 | Russler-Germain et al. 2023 |
146
+| [MGEA5](MGEA5) | 2 | Hübschmann et al. 2021 |
147
+| [MKI67](MKI67) | 2 | Russler-Germain et al. 2023; Schmitz et al. 2012 |
148
+| [MYC](MYC) | 2, aSHM | Johnston and Carroll 1992; L. Pasqualucci et al. 2001; Jallades et al. 2017; Duns et al. 2021 |
149
+| [MYCBP2](MYCBP2) | 2 | Hübschmann et al. 2021 |
150
+| [MYD88](MYD88) | 2 | Ngo et al. 2011; Yan et al. 2012 |
151
+| [NFKBIA](NFKBIA) | 2 | Wienand et al. 2019; Russler-Germain et al. 2023; Lake et al. 2009 |
152
+| [OR8H2](OR8H2) | 2 | Russler-Germain et al. 2023 |
153
+| [P2RY8](P2RY8) | 2 | Muppidi et al. 2014; Lohr et al. 2012 |
154
+| [PDS5B](PDS5B) | 2 | Morin et al. 2013; Hübschmann et al. 2021 |
155
+| [PPP4C](PPP4C) | 2 | Hübschmann et al. 2021 |
156
+| [PRKDC](PRKDC) | 2 | Schmitz et al. 2018; Hübschmann et al. 2021 |
157
+| [PZP](PZP) | 2 | Russler-Germain et al. 2023 |
158
+| [RBM6](RBM6) | 2 | Hübschmann et al. 2021 |
159
+| [SESN1](SESN1) | 2 | Oricchio et al. 2017 |
160
+| [SHROOM3](SHROOM3) | 2 | Russler-Germain et al. 2023 |
161
+| [SRRM2](SRRM2) | 2 | Morin et al. 2013; Russler-Germain et al. 2023 |
162
+| [STAB2](STAB2) | 2 | Russler-Germain et al. 2023 |
163
+| [TMEM30A](TMEM30A) | 2 | Morin et al. 2011 |
164
+| [TPP1](TPP1) | 2 | Hübschmann et al. 2021 |
165
+| [XIRP2](XIRP2) | 2 | Russler-Germain et al. 2023 |
166
+| [ZC3H12A](ZC3H12A) | 2 | Arthur et al. 2018 |
167
+| [ZNF608](ZNF608) | 2 | Zhang et al. 2013; Krysiak et al. 2017 |
169 168
170 169
# References
171 170
... ...
@@ -263,6 +262,43 @@ class="nocase">B-cell</span> Lymphoma.” *Nature* 459 7247: 717–21.
263 262
264 263
</div>
265 264
265
+<div id="ref-deschGenotypingCirculatingTumor2020" class="csl-entry">
266
+
267
+Desch, Ann-Kathrin, Kristin Hartung, Ante Botzen, Alexander Brobeil,
268
+Mathias Rummel, Lars Kurch, Thomas Georgi, et al. 2020. “Genotyping
269
+Circulating Tumor DNA of Pediatric Hodgkin Lymphoma.” *Leukemia* 34 1:
270
+151–66. <https://doi.org/10.1038/s41375-019-0541-6>.
271
+
272
+</div>
273
+
274
+<div id="ref-dunsCharacterizationDLBCLPMBL2021b" class="csl-entry">
275
+
276
+Duns, Gerben, Elena Viganò, Daisuke Ennishi, Clementine Sarkozy, Stacy
277
+S. Hung, Elizabeth Chavez, Katsuyoshi Takata, et al. 2021.
278
+“Characterization of DLBCL with a PMBL Gene Expression Signature.”
279
+*Blood* 138 2: 136–48. <https://doi.org/10.1182/blood.2020007683>.
280
+
281
+</div>
282
+
283
+<div id="ref-ganapathiGeneticLandscapeDural2016" class="csl-entry">
284
+
285
+Ganapathi, Karthik A., Vaidehi Jobanputra, Fabio Iwamoto, Preti Jain,
286
+Jinli Chen, Luciano Cascione, Odelia Nahum, et al. 2016. “The Genetic
287
+Landscape of Dural Marginal Zone Lymphomas.” *Oncotarget* 7 28:
288
+43052–61. <https://doi.org/10.18632/oncotarget.9678>.
289
+
290
+</div>
291
+
292
+<div id="ref-gomezUltraDeepSequencingReveals2023" class="csl-entry">
293
+
294
+Gomez, Felicia, Bryan Fisk, Joshua F. McMichael, Matthew Mosior,
295
+Jennifer A. Foltz, Zachary L. Skidmore, Eric J. Duncavage, et al. 2023.
296
+“Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical
297
+Hodgkin Lymphoma.” *Cancer Research Communications* 3 11: 2312–30.
298
+<https://doi.org/10.1158/2767-9764.CRC-23-0140>.
299
+
300
+</div>
301
+
266 302
<div id="ref-grandeGenomewideDiscoverySomatic2019" class="csl-entry">
267 303
268 304
Grande, Bruno M., Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner,
... ...
@@ -285,6 +321,17 @@ Germinal Center Derived <span class="nocase">B-cell</span> Lymphomas.”
285 321
286 322
</div>
287 323
324
+<div id="ref-jalladesExomeSequencingIdentifies2017" class="csl-entry">
325
+
326
+Jallades, Laurent, Lucile Baseggio, Pierre Sujobert, Sarah Huet, Kaddour
327
+Chabane, Evelyne Callet-Bauchu, Aurélie Verney, et al. 2017. “Exome
328
+Sequencing Identifies Recurrent BCOR Alterations and the Absence of
329
+KLF2, TNFAIP3 and MYD88 Mutations in Splenic Diffuse Red Pulp Small
330
+<span class="nocase">B-cell</span> Lymphoma.” *Haematologica* 102 10:
331
+1758–66. <https://doi.org/10.3324/haematol.2016.160192>.
332
+
333
+</div>
334
+
288 335
<div id="ref-johnstonCmycHypermutationBurkitt1992" class="csl-entry">
289 336
290 337
Johnston, J. M., and W. L. Carroll. 1992. “C-Myc Hypermutation in
... ...
@@ -409,6 +456,16 @@ Lymphoma Using Whole-Genome Sequencing.” *Blood* 122 7: 1256–65.
409 456
410 457
</div>
411 458
459
+<div id="ref-mottokIntegrativeGenomicAnalysis2019b" class="csl-entry">
460
+
461
+Mottok, Anja, Stacy S. Hung, Elizabeth A. Chavez, Bruce Woolcock, Adèle
462
+Telenius, Lauren C. Chong, Barbara Meissner, et al. 2019. “Integrative
463
+Genomic Analysis Identifies Key Pathogenic Mechanisms in Primary
464
+Mediastinal Large <span class="nocase">B-cell</span> Lymphoma.” *Blood*
465
+134 10: 802–13. <https://doi.org/10.1182/blood.2019001126>.
466
+
467
+</div>
468
+
412 469
<div id="ref-muppidiLossSignalingGa132014b" class="csl-entry">
413 470
414 471
Muppidi, J., R. Schmitz, Jesse A. Green, Jesse A. Green, Wenming Xiao,
... ...
@@ -479,6 +536,16 @@ Exome and Genome Sequencing.” *Blood* 136 5: 572–84.
479 536
480 537
</div>
481 538
539
+<div id="ref-parryWholeExomeSequencing2013" class="csl-entry">
540
+
541
+Parry, Marina, Matthew J. J. Rose-Zerilli, Jane Gibson, Sarah Ennis,
542
+Renata Walewska, Jade Forster, Helen Parker, et al. 2013. “Whole Exome
543
+Sequencing Identifies Novel Recurrently Mutated Genes in Patients with
544
+Splenic Marginal Zone Lymphoma.” *PloS One* 8 12: e83244.
545
+<https://doi.org/10.1371/journal.pone.0083244>.
546
+
547
+</div>
548
+
482 549
<div id="ref-pasqualucciInactivatingMutationsAcetyltransferase2011a"
483 550
class="csl-entry">
484 551
... ...
@@ -520,6 +587,16 @@ and Functional Drivers of Diffuse Large B Cell Lymphoma.” *Cell* 171
520 587
521 588
</div>
522 589
590
+<div id="ref-reichelFlowSortingExome2015a" class="csl-entry">
591
+
592
+Reichel, Jonathan, Amy Chadburn, Paul G. Rubinstein, Lisa Giulino-Roth,
593
+Wayne Tam, Yifang Liu, Rafael Gaiolla, et al. 2015. “Flow Sorting and
594
+Exome Sequencing Reveal the Oncogenome of Primary Hodgkin and
595
+Reed-Sternberg Cells.” *Blood* 125 7: 1061–72.
596
+<https://doi.org/10.1182/blood-2014-11-610436>.
597
+
598
+</div>
599
+
523 600
<div id="ref-richterRecurrentMutationID32012a" class="csl-entry">
524 601
525 602
Richter, Julia, Matthias Schlesner, Steve Hoffmann, Markus Kreuz, Ellen
... ...
@@ -530,6 +607,39 @@ Genome, Exome and Transcriptome Sequencing.” *Nature Genetics* 44 12:
530 607
531 608
</div>
532 609
610
+<div id="ref-ritzRecurrentMutationsSTAT62009a" class="csl-entry">
611
+
612
+Ritz, Olga, Chrystelle Guiter, Flavia Castellano, Karola Dorsch, Julia
613
+Melzner, Jean-Philippe Jais, Gwendoline Dubois, Philippe Gaulard, Peter
614
+Möller, and Karen Leroy. 2009. “Recurrent Mutations of the STAT6 DNA
615
+Binding Domain in Primary Mediastinal <span class="nocase">B-cell</span>
616
+Lymphoma.” *Blood* 114 6: 1236–42.
617
+<https://doi.org/10.1182/blood-2009-03-209759>.
618
+
619
+</div>
620
+
621
+<div id="ref-rossiAlterationBIRC3Multiple2011a" class="csl-entry">
622
+
623
+Rossi, Davide, Silvia Deaglio, David Dominguez-Sola, Silvia Rasi,
624
+Tiziana Vaisitti, Claudio Agostinelli, Valeria Spina, et al. 2011.
625
+“Alteration of BIRC3 and Multiple Other <span
626
+class="nocase">NF-κB</span> Pathway Genes in Splenic Marginal Zone
627
+Lymphoma.” *Blood* 118 18: 4930–34.
628
+<https://doi.org/10.1182/blood-2011-06-359166>.
629
+
630
+</div>
631
+
632
+<div id="ref-rossiCodingGenomeSplenic2012c" class="csl-entry">
633
+
634
+Rossi, Davide, Vladimir Trifonov, Marco Fangazio, Alessio Bruscaggin,
635
+Silvia Rasi, Valeria Spina, Sara Monti, et al. 2012. “The Coding Genome
636
+of Splenic Marginal Zone Lymphoma: Activation of NOTCH2 and Other
637
+Pathways Regulating Marginal Zone Development.” *The Journal of
638
+Experimental Medicine* 209 9: 1537–51.
639
+<https://doi.org/10.1084/jem.20120904>.
640
+
641
+</div>
642
+
533 643
<div id="ref-russler-germainMutationsAssociatedProgression2023b"
534 644
class="csl-entry">
535 645
... ...
@@ -542,6 +652,26 @@ Advances* 7: 5524–39.
542 652
543 653
</div>
544 654
655
+<div id="ref-sarkozyMutationalLandscapeGray2021a" class="csl-entry">
656
+
657
+Sarkozy, Clémentine, Stacy S. Hung, Elizabeth A. Chavez, Gerben Duns,
658
+Katsuyoshi Takata, Lauren C. Chong, Tomohiro Aoki, et al. 2021.
659
+“Mutational Landscape of Gray Zone Lymphoma.” *Blood* 137 13: 1765–76.
660
+<https://doi.org/10.1182/blood.2020007507>.
661
+
662
+</div>
663
+
664
+<div id="ref-schmitzTNFAIP3A20Tumor2009a" class="csl-entry">
665
+
666
+Schmitz, Roland, Martin-Leo Hansmann, Verena Bohle, Jose Ignacio
667
+Martin-Subero, Sylvia Hartmann, Gunhild Mechtersheimer, Wolfram Klapper,
668
+et al. 2009. “TNFAIP3 A20 Is a Tumor Suppressor Gene in Hodgkin
669
+Lymphoma and Primary Mediastinal B Cell Lymphoma.” *The Journal of
670
+Experimental Medicine* 206 5: 981–89.
671
+<https://doi.org/10.1084/jem.20090528>.
672
+
673
+</div>
674
+
545 675
<div id="ref-schmitzGeneticsPathogenesisDiffuse2018a" class="csl-entry">
546 676
547 677
Schmitz, Roland, George W. Wright, Da Wei Huang, Calvin A. Johnson,
... ...
@@ -582,6 +712,15 @@ Cases.” *Annals of Laboratory Medicine* 35 2: 257–59.
582 712
583 713
</div>
584 714
715
+<div id="ref-spinaGeneticsNodalMarginal2016b" class="csl-entry">
716
+
717
+Spina, Valeria, Hossein Khiabanian, Monica Messina, Sara Monti, Luciano
718
+Cascione, Alessio Bruscaggin, Elisa Spaccarotella, et al. 2016. “The
719
+Genetics of Nodal Marginal Zone Lymphoma.” *Blood* 128 10: 1362–73.
720
+<https://doi.org/10.1182/blood-2016-02-696757>.
721
+
722
+</div>
723
+
585 724
<div id="ref-tanakaFrequentIncidenceSomatic1992" class="csl-entry">
586 725
587 726
Tanaka, S., D. C. Louie, J. A. Kant, and J. C. Reed. 1992. “Frequent
... ...
@@ -600,6 +739,36 @@ Lymphoma.” *Blood* 141 8: 904–16.
600 739
601 740
</div>
602 741
742
+<div id="ref-tiacciPervasiveMutationsJAKSTAT2018b" class="csl-entry">
743
+
744
+Tiacci, Enrico, Erik Ladewig, Gianluca Schiavoni, Alex Penson,
745
+Elisabetta Fortini, Valentina Pettirossi, Yuchun Wang, et al. 2018.
746
+“Pervasive Mutations of JAK-STAT Pathway Genes in Classical Hodgkin
747
+Lymphoma.” *Blood* 131 22: 2454–65.
748
+<https://doi.org/10.1182/blood-2017-11-814913>.
749
+
750
+</div>
751
+
752
+<div id="ref-wenigerMutationsTumorSuppressor2006a" class="csl-entry">
753
+
754
+Weniger, M. A., I. Melzner, C. K. Menz, S. Wegener, A. J. Bucur, K.
755
+Dorsch, T. Mattfeldt, T. F. E. Barth, and P. Möller. 2006. “Mutations of
756
+the Tumor Suppressor Gene SOCS-1 in Classical Hodgkin Lymphoma Are
757
+Frequent and Associated with Nuclear Phospho-STAT5 Accumulation.”
758
+*Oncogene* 25 18: 2679–84. <https://doi.org/10.1038/sj.onc.1209151>.
759
+
760
+</div>
761
+
762
+<div id="ref-wienandGenomicAnalysesFlowsorted2019b" class="csl-entry">
763
+
764
+Wienand, Kirsty, Bjoern Chapuy, Chip Stewart, Andrew J. Dunford, David
765
+Wu, Jaegil Kim, Atanas Kamburov, et al. 2019. “Genomic Analyses of
766
+Flow-Sorted Hodgkin Reed-Sternberg Cells Reveal Complementary Mechanisms
767
+of Immune Evasion.” *Blood Advances* 3 23: 4065–80.
768
+<https://doi.org/10.1182/bloodadvances.2019001012>.
769
+
770
+</div>
771
+
603 772
<div id="ref-wildaInactivationARFMDM2p53Pathway2004" class="csl-entry">
604 773
605 774
Wilda, M., J. Bruch, L. Harder, D. Rawer, A. Reiter, A. Borkhardt, and
... ...
@@ -620,6 +789,17 @@ Recurrent CARD11 Mutations.” *Oncotarget* 7 25: 38180–90.
620 789
621 790
</div>
622 791
792
+<div id="ref-yanBCRTLRSignaling2012a" class="csl-entry">
793
+
794
+Yan, Qingguo, Yuanxue Huang, A. James Watkins, Sylvia Kocialkowski,
795
+Naiyan Zeng, Rifat A. Hamoudi, Peter G. Isaacson, Laurence de Leval,
796
+Andrew Wotherspoon, and Ming-Qing Du. 2012. “BCR and TLR Signaling
797
+Pathways Are Recurrently Targeted by Genetic Changes in Splenic Marginal
798
+Zone Lymphomas.” *Haematologica* 97 4: 595–98.
799
+<https://doi.org/10.3324/haematol.2011.054080>.
800
+
801
+</div>
802
+
623 803
<div id="ref-yildizActivatingSTAT6Mutations2015c" class="csl-entry">
624 804
625 805
Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter